Posts
ImmunoForge to Showcase Proprietary Platform Technologies and Next-Generation Oncology & Phase 2 Clinical Pipelines at BIO-Europe 2026
Source: PR Newswire · ImmunoForge Co., Ltd. · View original release SEOUL, South Korea and COLOGNE, Germany, Oct. 23, 2026 /PRNewswire/ -- ImmunoForge Co., Ltd.,...
Visa Partners Singapore Tourism Board to Strengthen Singapore’s Global Destination Appeal
Source: PR Newswire · Visa · View original release SINGAPORE, Oct. 23, 2026 /PRNewswire/ -- Visa, a global leader in digital payments and the Singapore...
California Waste Solutions Leads Youth Education, Worker Programs & Government Delegations As Founder David Duong Says He Will Continue “Reinvesting” In Vietnam
Source: PR Newswire · California Waste Solutions · View original release David Duong supports environmental education for young people in Vietnam while workers at Vietnam...
Anchanto Partners with JINGDONG Logistics to Help South Korean Brands Sell Across Global Marketplaces
Source: PR Newswire · Anchanto · View original releaseJINGDONG Logistics will onboard customers through Anchanto's Operations Experience (OXM) platform, connecting online sales channels to logistics...
Ascletis’ Strategic Partner Sagimet Announces First Patient Dosed in Phase III U.S. Clinical Trial of Denifanstat (ASC40) for Moderate to Severe Acne
Source: PR Newswire · Ascletis Pharma Inc. · View original release - With first patient dosed in Phase III clinical trial, Ascletis' strategic partner Sagimet...
Scage Future Announces Effective Date for ADS Ratio Change
Source: PR Newswire · Scage Future · View original release NANJING, China, Oct. 23, 2026 /PRNewswire/ -- Scage Future ("Scage Future" or the "Company") (Nasdaq:...
Harbour BioMed Receives China NMPA Approval of Batoclimab Injection (Subcutaneous Injection) for the Treatment of Generalized Myasthenia Gravis
Source: PR Newswire · Harbour BioMed · View original release The first NMPA-approved anti-FcRn therapy to complete its full clinical development for gMG patients in...
